Skip to content

Member

András Tivadar KULJA

EPP · Hungary

Group
EPP PPE
Country
Hungary
Roll-call participation
71.1 %ⓘ of 620 roll calls in office · chamber median 90.6 % · whole term, final votes
With majority line
83.7 %ⓘ of 441 votes where the group had a line · EPP median 95.6 %
More facts (5)
National party
TISZA Tisztelet és Szabadság Párt
In office
Since 16 Jul 2024
Against clear line
41 of 410 votesⓘ
Committees
ENVI (vice-chair), SANT
Member id
256864
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

71.1 %

441 of 620 final votes while in office

EPP median: 90.6 % (−19.4 pts)

Chamber median: 90.6 %

With majority line ⓘ

83.7 %

369 of 441 votes where their group had a line

EPP median: 95.6 % (−11.9 pts)

Against clear line ⓘ

10.0 %

41 of 410 votes where their group had a clear line

14 opposite (for ↔ against), 27 abstained against the line

Abstention ⓘ

8.8 %

39 of 441 votes cast

Participation 71.1 % — EPP median 90.6 %, 192 members.ⓘ
Data as a table
Participation among the 192 members of the EPP with enough votes.
FigureParticipation
András Tivadar KULJA71.1 %
EPP median90.6 %
Lowest in the group18.4 %
Highest in the group99.8 %
Members192
With majority line 83.7 % — EPP median 95.6 %, 192 members.ⓘ
Data as a table
With majority line among the 192 members of the EPP with enough votes.
FigureWith majority line
András Tivadar KULJA83.7 %
EPP median95.6 %
Lowest in the group67.8 %
Highest in the group99.0 %
Members192
  • Whole term, 620 final votes; 620 of 794 decisions had a final vote recorded by name. The dots are the other members of EPP; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 5 928

Export

Every roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecision and voteResultPositionMajority line
30 Apr 2026Shortcomings and deficiencies of the ‘Amnesty Law’ in Venezuela Amendment 2 to paragraph 5 157 for, 329 against, 69 abstainedPosition: Against Majority line: Against
30 Apr 2026Shortcomings and deficiencies of the ‘Amnesty Law’ in Venezuela Amendment 8 to paragraph 4 83 for, 465 against, 24 abstainedPosition: Against Majority line: Against
30 Apr 2026Shortcomings and deficiencies of the ‘Amnesty Law’ in Venezuela Amendment 6 to paragraph 2 49 for, 504 against, 20 abstainedPosition: Against Majority line: Against
30 Apr 2026New Chinese law on ‘ethnic unity and progress’ and the intensified suppression of ethnic identities Final vote — text as a wholeAdopted 439 for, 52 against, 71 abstainedPosition: No vote recorded Majority line: For
30 Apr 2026New Chinese law on ‘ethnic unity and progress’ and the intensified suppression of ethnic identities Amendment 1 to paragraph 4 104 for, 377 against, 86 abstainedPosition: Against Majority line: Against
30 Apr 2026Escalating trafficking and exploitation by criminal groups in Haiti Final vote — text as a wholeAdopted 511 for, 21 against, 42 abstainedPosition: For Majority line: For
30 Apr 2026Escalating trafficking and exploitation by criminal groups in Haiti Amendment 4, adding text after recital B 86 for, 415 against, 66 abstainedPosition: Against Majority line: Against
30 Apr 2026Escalating trafficking and exploitation by criminal groups in Haiti Paragraph 6 — part 2 370 for, 180 against, 19 abstainedPosition: For Majority line: For
30 Apr 2026Escalating trafficking and exploitation by criminal groups in Haiti Amendment 3 to paragraph 6 99 for, 427 against, 40 abstainedPosition: Against Majority line: Against
30 Apr 2026Escalating trafficking and exploitation by criminal groups in Haiti Amendment 8, adding text after paragraph 5 84 for, 464 against, 11 abstainedPosition: Against Majority line: Against
29 Apr 2026Genetically modified soybean MON 94637 Final vote on the motion for a resolutionObjection passed 412 for, 145 against, 11 abstainedPosition: Abstained Majority line: Against
29 Apr 2026Monitoring the application of European Union law in 2023, 2024 and 2025 Final vote — text as a wholeAdopted 416 for, 190 against, 15 abstainedPosition: For Majority line: For
29 Apr 2026Monitoring the application of European Union law in 2023, 2024 and 2025 Amendment 6, adding text after recital D 187 for, 419 against, 16 abstainedPosition: Abstained ≠ groupMajority line: Against
29 Apr 2026Monitoring the application of European Union law in 2023, 2024 and 2025 Amendment 11, adding text after paragraph 48 195 for, 419 against, 12 abstainedPosition: For ≠ groupMajority line: Against
29 Apr 2026Monitoring the application of European Union law in 2023, 2024 and 2025 Amendment 29, adding text after paragraph 36 202 for, 423 against, 1 abstainedPosition: Against Majority line: Against
29 Apr 2026Monitoring the application of European Union law in 2023, 2024 and 2025 Amendment 28, adding text after paragraph 36 205 for, 403 against, 9 abstainedPosition: Against Majority line: Against
29 Apr 2026Monitoring the application of European Union law in 2023, 2024 and 2025 Amendment 14 to paragraph 36 202 for, 424 against, 1 abstainedPosition: Against Majority line: Against
29 Apr 2026Monitoring the application of European Union law in 2023, 2024 and 2025 Amendment 13, adding text after paragraph 31 193 for, 421 against, 8 abstainedPosition: Against Majority line: Against
29 Apr 2026Monitoring the application of European Union law in 2023, 2024 and 2025 Amendment 25, adding text after paragraph 22 195 for, 420 against, 6 abstainedPosition: Against Majority line: Against
29 Apr 2026Monitoring the application of European Union law in 2023, 2024 and 2025 Amendment 24 to paragraph 19 189 for, 425 against, 9 abstainedPosition: Against Majority line: Against
29 Apr 2026Monitoring the application of European Union law in 2023, 2024 and 2025 Amendment 8, adding text after paragraph 17 197 for, 421 against, 4 abstainedPosition: Against Majority line: Against
29 Apr 2026Monitoring the application of European Union law in 2023, 2024 and 2025 Amendment 22 to paragraph 17 198 for, 417 against, 1 abstainedPosition: No vote recorded Majority line: Against
29 Apr 2026Monitoring the application of European Union law in 2023, 2024 and 2025 Amendment 12, adding text after paragraph 12 193 for, 428 against, 5 abstainedPosition: Against Majority line: Against
29 Apr 2026Monitoring the application of European Union law in 2023, 2024 and 2025 Amendment 7, adding text after paragraph 6 212 for, 406 against, 7 abstainedPosition: Abstained ≠ groupMajority line: Against
29 Apr 2026Monitoring the application of European Union law in 2023, 2024 and 2025 Paragraph 2 — part 2 407 for, 190 against, 25 abstainedPosition: For Majority line: For
29 Apr 2026The Commission’s 2025 Rule of Law report Final vote — text as a wholeAdopted 387 for, 191 against, 46 abstainedPosition: For Majority line: For
29 Apr 2026The Commission’s 2025 Rule of Law report Amendment 14 to recital R 220 for, 399 against, 5 abstainedPosition: Against Majority line: Against
29 Apr 2026The Commission’s 2025 Rule of Law report Amendment 12 to paragraph 185 185 for, 426 against, 13 abstainedPosition: Against Majority line: Against
29 Apr 2026The Commission’s 2025 Rule of Law report Amendment 11 to paragraph 168 201 for, 419 against, 4 abstainedPosition: No vote recorded Majority line: Against
29 Apr 2026The Commission’s 2025 Rule of Law report Amendment 13, adding text after paragraph 155 282 for, 334 against, 14 abstainedPosition: Against Majority line: Against
29 Apr 2026The Commission’s 2025 Rule of Law report Amendment 10 to paragraph 126 192 for, 418 against, 12 abstainedPosition: Against Majority line: Against
29 Apr 2026The Commission’s 2025 Rule of Law report Amendment 20, adding text after paragraph 118 197 for, 416 against, 9 abstainedPosition: No vote recorded Majority line: Against
29 Apr 2026The Commission’s 2025 Rule of Law report Separate vote on paragraph 117 336 for, 261 against, 29 abstainedPosition: Against Majority line: Against
29 Apr 2026The Commission’s 2025 Rule of Law report Amendment 9 to paragraph 116 188 for, 422 against, 14 abstainedPosition: Against Majority line: Against
29 Apr 2026The Commission’s 2025 Rule of Law report Amendment 8, adding text after paragraph 113 218 for, 401 against, 8 abstainedPosition: Abstained ≠ groupMajority line: Against
29 Apr 2026The Commission’s 2025 Rule of Law report Paragraph 112 — part 3 284 for, 335 against, 6 abstainedPosition: Against Majority line: Against
29 Apr 2026The Commission’s 2025 Rule of Law report Paragraph 112 — part 2 408 for, 192 against, 22 abstainedPosition: For Majority line: For
29 Apr 2026The Commission’s 2025 Rule of Law report Paragraph 112 — part 1 498 for, 80 against, 57 abstainedPosition: For Majority line: For
29 Apr 2026The Commission’s 2025 Rule of Law report Amendment 7 to paragraph 112 207 for, 410 against, 9 abstainedPosition: No vote recorded Majority line: Against
29 Apr 2026The Commission’s 2025 Rule of Law report Amendment 6 to paragraph 103 205 for, 419 against, 4 abstainedPosition: Against Majority line: Against
29 Apr 2026The Commission’s 2025 Rule of Law report Separate vote on paragraph 102 291 for, 240 against, 74 abstainedPosition: No vote recorded Majority line: Abstained
29 Apr 2026The Commission’s 2025 Rule of Law report Separate vote on paragraph 101 365 for, 168 against, 78 abstainedPosition: Abstained Majority line: For
29 Apr 2026The Commission’s 2025 Rule of Law report Separate vote on paragraph 100 357 for, 203 against, 45 abstainedPosition: No vote recorded Majority line: For
29 Apr 2026The Commission’s 2025 Rule of Law report Amendment 5 to paragraph 91 207 for, 406 against, 3 abstainedPosition: Against Majority line: Against
29 Apr 2026The Commission’s 2025 Rule of Law report Amendment 4, adding text after paragraph 86 200 for, 411 against, 12 abstainedPosition: Abstained ≠ groupMajority line: Against
29 Apr 2026The Commission’s 2025 Rule of Law report Amendment 3 to paragraph 77 196 for, 422 against, 6 abstainedPosition: Against Majority line: Against
29 Apr 2026The Commission’s 2025 Rule of Law report Amendment 2, adding text after paragraph 65 194 for, 417 against, 15 abstainedPosition: Against Majority line: Against
29 Apr 2026The Commission’s 2025 Rule of Law report Amendment 17 to paragraph 55 200 for, 419 against, 7 abstainedPosition: Against Majority line: Against
29 Apr 2026The Commission’s 2025 Rule of Law report Amendment 16 to paragraph 44 181 for, 419 against, 22 abstainedPosition: Against Majority line: Against
29 Apr 2026The Commission’s 2025 Rule of Law report Amendment 15 to paragraph 38 206 for, 408 against, 10 abstainedPosition: Against Majority line: Against

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 14 of 80 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within EPP

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Eszter LAKOS EPPHungary99 % of 3 274 shared89 %
Dóra DÁVID EPPHungary99 % of 3 586 shared89 %
Gabriella GERZSENYI EPPHungary99 % of 2 356 shared89 %
Kinga KOLLÁR EPPHungary99 % of 3 067 shared89 %
Zoltán TARR Former memberEPPHungary97 % of 1 796 shared89 %
Péter MAGYAR Former memberEPPHungary93 % of 682 shared89 %
Willemien KONING EPPNetherlands89 % of 1 213 shared89 %
Marie-Sophie CHRIST EPPGermany88 % of 1 291 shared89 %
Manfred WEBER EPPGermany88 % of 2 850 shared89 %
Martine KEMP EPPLuxembourg87 % of 2 916 shared89 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Jérémy DECERLE RenewFrance79 % of 1 750 shared82 %
Ivars IJABS RenewLatvia78 % of 2 812 shared82 %
Sophie WILMÈS RenewBelgium78 % of 2 466 shared82 %
Urmas PAET RenewEstonia78 % of 3 122 shared82 %
Hilde VAUTMANS RenewBelgium78 % of 3 514 shared82 %
Nathalie LOISEAU RenewFrance78 % of 2 822 shared82 %
Eugen TOMAC RenewRomania77 % of 2 398 shared82 %
Gilles BOYER RenewFrance77 % of 3 612 shared82 %
Benoit CASSART RenewBelgium77 % of 3 409 shared82 %
Grégory ALLIONE RenewFrance77 % of 3 203 shared82 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on the Environment, Climate and Food SafetyENVI CommitteeVice-chair20 Jan 2025now
Committee on Public HealthSANT CommitteeMember23 Jan 2025now
Delegation for relations with CanadaD-CA DelegationSubstitute12 Jun 2026now
Delegation for relations with the Korean PeninsulaDKOR DelegationSubstitute19 Sept 2024now
Intergroup on Anti-CorruptionIG10-01 Intergroup / working groupMember16 Jan 2025now
Intergroup on Cancer and Rare DiseasesIG10-05 Intergroup / working groupMember27 Jan 2025now
Intergroup on DisabilityIG10-10 Intergroup / working groupMember11 Mar 2025now
Intergroup on Mental HealthIG10-17 Intergroup / working groupMember5 Feb 2025now
Intergroup on Traditional Minorities, National Communities and LanguagesIG10-25 Intergroup / working groupMember5 Feb 2025now
Committee on Employment and Social AffairsEMPL CommitteeSubstitute19 Jul 202411 Jun 2026

Show all 13 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
No dossier namedOfficial delegationSANT2 Sept 2026
No dossier namedOfficial delegationSANT22 Apr 2026
No dossier namedOfficial delegationSANT29 Jan 2026
An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sectorShadow rapporteurSANT8 Oct 2025
Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795Shadow rapporteur for an opinionENVI19 Jun 2025
No dossier namedOfficial delegationENVI17 Mar 2025
Implementation and delivery of the Sustainable Development Goals in view of the 2025 High-Level Political ForumShadow rapporteurENVI24 Feb 2025
Safety of toysShadow rapporteur for an opinionENVI14 Nov 2024
No dossier namedOfficial delegation25 Oct 2024
No dossier namedOfficial delegation11 Sept 2024

Show all 11 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

39 contributions recorded, 2 written statements; 4 on behalf of their group; 54 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
DateDebateKindVerbatim
17 Sept 2026Protecting people’s health against toxic substances (debate) Speech · 1 minRead
17 Sept 2026An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector (debate) on behalf of EPPSpeech · 2 minRead
15 Sept 2026Findings and recommendations of the Special Committee on the European Democracy Shield (debate) Speech · 1 minRead
15 Sept 2026Devastating heatwaves, wildfires and droughts in Europe: lessons from summer 2026 (debate) Speech · 1 minRead
11 Feb 2026Rule of law, fundamental rights and misuse of EU funds in Slovakia: the need for an EU response (debate) Speech · 1 minRead
19 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest (debate) on behalf of EPPSpeech · 2 minRead
16 Dec 2025Presentation of the EU Cardiovascular Health Plan (debate) Speech · 1 minRead
16 Dec 2025Presentation of the EU Cardiovascular Health Plan (debate) Speech · 2 minRead
15 Dec 2025Impact of the geopolitical situation on European patients and their access to medicines (debate) Speech · 2 minRead
23 Oct 2025Breast cancer: the importance of screening (debate) StatementRead

Show all 39 recent contributions

Questions and motions, 14

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
18 May 2026Access to reliable clinical performance data and regulatory oversight of CGM systems in the EU E-10-2026-002029Written question17 Jul 2026
11 Feb 2026Request for an assessment of land confiscation practices and of the criminalisation of public criticism of historical legislation in Slovakia P-10-2026-000603Priority written questionwith 6 co-authors30 Apr 2026
22 Dec 2025Serious concerns regarding compliance with European values and EU law in Slovakia E-10-2025-005054Written questionwith 12 co-authors21 Apr 2026
20 Dec 2025Implementation of EU anti-poverty strategy based on accurate data E-10-2025-005037Written questionwith 5 co-authors25 Feb 2026
23 Sept 2025Newborn screening for access to advanced life-saving therapies E-10-2025-003675Written questionwith 3 co-authors21 Nov 2025
17 Jun 2025The role of local authorities in addressing the financial and operational challenges posed by PFAS and other persistent chemical contaminants in Europe E-10-2025-002429Written questionwith 20 co-authors26 Aug 2025
29 Apr 2025Strengthening workplace health and safety to prevent sudden cardiac arrest deaths E-10-2025-001716Written question13 Jun 2025
26 Feb 2025Rare diseases P-10-2025-000845Priority written questionwith 7 co-authors2 May 2025
21 Feb 2025Commission’s response to the incomplete implementation of the UN Convention on the Rights of Persons with Disabilities in Member States E-10-2025-000810Written questionwith 50 co-authors27 May 2025
20 Jan 2025Infection prevention and action against antimicrobial resistance, including innovative therapies E-10-2025-000213Written question18 Mar 2025

Show all 14 questions and motions

Amendments tabled in committee, 52

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792014 SANT26
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792154 SANT5
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791891 SANT3
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791887 SANT9
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791890 SANT1
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790936 CJ535
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790937 CJ539
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790938 CJ531
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790939 CJ536
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790934 CJ536

Show all 52 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Hungary National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version 5a7357168c2a (28 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
28 September 2026

Cite as

EU Parl Watch Research (2026). “András Tivadar KULJA”. Member record. memberId 256864. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/256864?page=24&scope=final&vscope=all (retrieved 28 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/256864. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/256864?format=application%2Fld%2Bjson (CC BY 4.0); data version 5a7357168c2a (28 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-256864,
  author = {{EU Parl Watch Research}},
  title = {{András Tivadar KULJA}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/256864?page=24&scope=final&vscope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/256864?page=24&scope=final&vscope=all},
  urldate = {2026-09-28},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 256864. Official source: https://www.europarl.europa.eu/meps/en/256864. Data: EP Open Data: member record (CC BY 4.0); data version 5a7357168c2a (28 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}